In conflict with these data, a recent analysis of ANO7 messenger RNA (mRNA) expression from 289 PCa patients included in The Cancer Genome Atlas project8 suggested that increased ANO7 expression might indicate poor patient outcome9. This evidence concerns the gene ANO7 and posterior cortical atrophy.